
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
AusCann Group Holdings Ltd is a drug manufacturers-specialty & generic business based in Australia. AusCann Group shares (AC8) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. AusCann Group has a trailing 12-month revenue of around $1.3 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.125 - $0.3 |
---|---|
50-day moving average | $0.1638 |
200-day moving average | $0.1632 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.025 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.16
1 month (2021-03-12) | 6.67% |
---|
Revenue TTM | $1.3 million |
---|---|
Gross profit TTM | $-1,498,952 |
Return on assets TTM | -14.3% |
Return on equity TTM | -24.1% |
Profit margin | 0% |
Book value | 0.095 |
Market capitalisation | $44.4 million |
TTM: trailing 12 months
We're not expecting AusCann Group to pay a dividend over the next 12 months.
AusCann Group's shares were split on a 1:100 basis on 14 December 2010. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AusCann Group shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for AusCann Group shares which in turn could have impacted AusCann Group's share price.
Over the last 12 months, AusCann Group's shares have ranged in value from as little as $0.125 up to $0.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AusCann Group's is 1.5442. This would suggest that AusCann Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.
Steps to owning and managing Benz Mining shares.
Steps to owning and managing Top Shelf International shares.
Steps to owning and managing K12 Inc shares from Australia.
Steps to owning and managing 2U Inc shares from Australia.
Steps to owning and managing Chegg Inc shares from Australia.